CARVYKTI, Continued CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight 07.08.2025 - 18:04:32 DelveInsight Business Research, LLP United Kingdom United States of America +14699457679Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/carvykti-continued-performance-reflects-growing-confidence-in-car-t-therapies-for-multiple-myeloma--delveinsight-302407764.html